As of 2025-06-25, the EV/EBITDA ratio of Pieris Pharmaceuticals Inc (PIRS) is -5.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PIRS's latest enterprise value is 93.79 mil USD. PIRS's TTM EBITDA according to its financial statements is -18.00 mil USD. Dividing these 2 quantities gives us the above PIRS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 12.5x | 12.2x |
| Forward P/E multiples | 12.1x - 22.9x | 15.9x |
| Fair Price | (23.85) - (24.76) | (28.12) |
| Upside | -275.4% - -282.0% | -306.8% |
| Date | EV/EBITDA |